Skip to main content

What the FDA labels say about taking them together

Lithium and trandolapril

Trandolapril's FDA label of October 31, 2025 names lithium in its drug interactions section; the lithium labels PlainMeds reads (4) do not name trandolapril. The trandolapril label: “Lithium Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.”

Check it at the source: the lithium FDA label on DailyMed (effective December 23, 2025, Glenmark Pharmaceuticals Inc., USA); the trandolapril FDA label on DailyMed (effective October 31, 2025, Lupin Pharmaceuticals, Inc.).

What does the lithium label say about trandolapril?

Lithium's label (effective December 23, 2025) and its 3 other brand-application labels do not name trandolapril in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Lithium Carbonate), Glenmark Pharmaceuticals Inc., USA, effective December 23, 2025 (SPL set 63b3790f-a9b5-47f4-bae1-ddf8b43c13c1), via openFDA; the full label on DailyMed

What does the trandolapril label say about lithium?

Trandolapril label, drug interactions

Lithium Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.

Source: FDA drug label (Trandolapril), Lupin Pharmaceuticals, Inc., effective October 31, 2025 (SPL set 8143a6cf-dadc-4ef7-a8db-d16d7150ad34), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

24Lithium generic labelers
5Trandolapril generic labelers
LithiumTrandolapril
Labeled forBipolar disorderHigh blood pressure
Boxed warningYesYes
Pharmacy cost (NADAC)$0.104 per capsule 300 mg capsule$0.157 per tablet 1 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?